Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alexander Schlattau

Overcoming Resistance Against HER2-Targeting Agents in Fifth-Line Therapy: Is There Still a Place for Bevacizumab in HER2+ Breast Cancer?

Clinical Breast Cancer

Cancer Research

English

Related publications

Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer

New England Journal of Medicine

English

Src, a Potential Target for Overcoming Trastuzumab Resistance in HER2-positive Breast Carcinoma

British Journal of Cancer

Cancer Research

English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology

Cancer Research

Molecular Biology

English

HER2 Signaling Pathway Activation and Response of Breast Cancer Cells to HER2-targeting Agents Is Dependent Strongly on the 3D Microenvironment

Breast Cancer Research and Treatment

Cancer Research

English

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports

Multidisciplinary

English

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

Clinical Cancer Research

Cancer Research

English

Her2 Cross Talk and Therapeutic Resistance in Breast Cancer

Frontiers in Bioscience - Landmark

Molecular Biology

English

HER2-Orientated Therapy in Early and Metastatic Breast Cancer

English

Efficacy and Safety of HER2-Targeted Agents for Breast Cancer With HER2-Overexpression: A Network Meta-Analysis

Multidisciplinary

English